Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting – INTERNATIONAL JOURNAL OF DERMATOLOGY

Daudén, E; Escario, E; Martos-Cabrera, L; Armesto, S; Herrera-Acosta, E; Vidal, D; Vilarrasa, E; Rivera, R; de la Cueva, P; Martorell, A; Ballesca, F; Belinchón, I; Carretero, G; Rodríguez, L; Romero-Maté, A; Pujol-Montcusí, J; Salgado, L; Sahuquillo-Torralba, A; Coto-Segura, P; Baniandrés, O; Feltes, R; Riera-Monroig, J; Garrido, J; Llamas-Velasco, M – 2024 – 10.1111/ijd.16915